CRISPR Therapeutics AG Equity-NMS: CRSP

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$43.14

52W high :

$86.95

1Y :

-31.47%

5Y :

-21.65%

EPS(TTM): :

-8.36

Shares O/S :

78.65 M

Market cap :

3.42 B

What is the share price of CRISPR Therapeutics AG today?

CRISPR Therapeutics AG (CRSP) share price as of March 26, 2023, is $43.43. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of CRISPR Therapeutics AG?

Yes, Indian Investors can invest in the CRISPR Therapeutics AG (CRSP) Share by opening an international trading account with Angel One.

How can I purchase CRISPR Therapeutics AG shares in India?

Purchasing CRISPR Therapeutics AG (CRSP) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying CRISPR Therapeutics AG (CRSP) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of CRISPR Therapeutics AG?

Yes, you can purchase fractional shares of CRISPR Therapeutics AG (CRSP) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of CRISPR Therapeutics AG?

The market capitalization of CRISPR Therapeutics AG on March 26, 2023, is $3.42 B.

In which sector CRISPR Therapeutics AG belongs?

CRISPR Therapeutics AG operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in CRISPR Therapeutics AG stocks?

In order to invest in CRISPR Therapeutics AG (CRSP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.